Epithelial Junction Opener Improves Oncolytic Adenovirus Therapy in Mouse Tumor Models-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Epithelial Junction Opener Improves Oncolytic Adenovirus Therapy in Mouse Tumor Models

Published:2016-04 Issue:4 Volume:27 Page:325-337
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Yumul Roma¹,Richter Maximilian¹,Lu Zhuo-Zhuang¹²,Saydaminova Kamola¹,Wang Hongjie¹,Wang Chung-Huei Katherine³,Carter Darrick⁴⁵,Lieber André¹⁴⁶

Affiliation:

1. Division of Medical Genetics, University of Washington, Seattle, Washington.

2. National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, PR China.

3. BRIM Biotechnology Inc., Taipei, Taiwan.

4. Compliment Corp., Seattle, Washington.

5. PAI Life Sciences Inc., Seattle, Washington.

6. Department of Pathology, University of Washington, Seattle, Washington.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.2016.022

Reference64 articles.

1. Oncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic Applications

2. Replication-Competent Viruses as Cancer Immunotherapeutics: Emerging Clinical Data

3. Evidence for Oncolytic Virotherapy: Where Have We Got to and Where Are We Going?

4. Desmoglein 2 is expressed abnormally rather than mutated in familial and sporadic gastric cancer

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer therapy with the viral and bacterial pathogens: The past enemies can be considered the present allies;Life Sciences;2024-07

2. Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy;Nature Protocols;2024-05-20

3. SFXN1-mediated immune cell infiltration and tumorigenesis in lung adenocarcinoma: A potential therapeutic target;International Immunopharmacology;2024-05

4. Nanotechnology and nano-sized tools: Newer approaches to circumvent oncolytic adenovirus limitations;Pharmacology & Therapeutics;2024-04

5. Molecular insights and promise of oncolytic virus based immunotherapy;Advances in Protein Chemistry and Structural Biology;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3